Company intelligence / Profile preview

Viomedo

Berlin, Germany

Ownership: Private
Development stage: Other

Overview

Viomedo operated as a digital platform connecting patients with clinical trial opportunities. The platform served as Germany's largest clinical trial search engine and was the leading platform in the German-speaking DACH region. By 2017, the platform had matched over 30,000 patients with appropriate trials and had over 25,000 registered patients.

Therapeutic areas: NephrologyWomen's HealthEndocrinologyNeurologyDermatologyPulmonologyGastroenterologyOncologyOphthalmology
Industry: Contract Research Organization

Partnerships

Bayer Healthcare AGPfizerPatient advocacy groupsResearch institutionsContract research organizations

Beyond the preview

Go deeper on Viomedo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viomedo.

Explore the full profile